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Abstract Podocytes serve as the final barrier to urinary pro-
tein loss through a highly specialized structure called a slit
membrane and maintain foot process and glomerular base-
ment membranes. Podocyte injury results in progressive glo-
merular damage and accelerates sclerotic changes, although
the exact mechanism of podocyte injury is still obscure. We
focus on the staining gap (podocin gap) defined as the staining
difference between podocin and synaptopodin, which are nor-
mally located in the foot process. In puromycin
aminonucleoside nephrosis rats, the podocin gap is signifi-
cantly increased (p<0.05) and podocin is translocated to the
cytoplasm on days 7 and 14 but not on day 28. Surprisingly,
the gap is also significantly increased (p<0.05) in human kid-
ney biopsy specimens of poor-prognosis IgA nephropathy
patients. This suggests that the podocin gap could be a useful
marker for classifying the prognosis of IgA nephropathy and
indicating the translocation of podocin to the cytoplasm. Next,
we find more evidence of podocin trafficking in podocytes
where podocin merges with Rab5 in puromycin
aminonucleoside nephrosis rats at day 14. In immunoelectron
microscopy, the podocin positive area was significantly
translocated from the foot process areas to the cytoplasm
(p<0.05) on days 7 and 14 in puromycin aminonucleoside
nephrosis rats. Interestingly, podocin is also translocated to
the cytoplasm in poor-prognosis human IgA nephropathy. In
this paper, we demonstrate that the translocation of podocin by
endocytosis could be a key traffic event of critical podocyte
injury and that the podocin gap could indicate the prognosis of
IgA nephropathy.
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Introduction
Podocytes are specialized epithelial cells constituting an es-
sential part of the glomerular filtration barrier. Their interdig-
itated foot processes, connected by a slit diaphragm (SD),
together with fenestrated endothelial cells and an intervening
basement membrane, form the filtration barrier. The impor-
tance of podocyte integrity in the pathogenesis of nephrotic
syndrome is best illustrated by the identification of human
diseases causing mutations in genes encoding nephrin,
podocin and CD2AP that span and stitch together foot pro-
cesses of neighboring podocytes (Kestila et al. 1998;
Ruotsalainen et al. 1999; Boute et al. 2000).
In the podocyte, podocin localizes in the SD, where it is
assumed to act as an intercellular scaffold protein, assembling
SD components in lipid raft-associated microdomains
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(Tryggvason et al. 2006; Huber et al. 2003). Podocin is a
membrane-attached protein and it is predicted to form a
hairpin-like structure, with both N- and C-terminuses residing
in the cytoplasm (Schwarz et al. 2001). NPHS2 mutations
cause several diseases with an interference of podocin inter-
cellular trafficking (Roselli et al. 2004).
In mammalian cells, endocytosis is mediated via two
principal routes, i.e., clathrin-mediated endocytosis (CME)
and clathrin-independent, raft-mediated endocytosis (RME)
(Le Roy and Wrana 2005). CME targets proteins to the early
endosome, a sorting station directing vesicles to either
recycling or degradation. Besides this classic CME pathway,
RME has recently been the focus of intensive research,
uncovering the new concept that the microdomain itself be-
haves as a vehicle for internalization. RME is generally de-
fined by its clathrin independence, cholesterol sensitivity and
a typical morphology of smooth invaginations (Mayor and
Pagano 2007).
Shono et al. (2007) demonstrated that podocin co-localizes
with the coxsaxie virus and adeno virus receptor (CAR) and
with ZO-1 at the tight junction between foot processes in
puromycin aminonucleoside (PA) nephrosis (PAN) rat kid-
neys and podocin facilitated the coalescence of lipid rafts con-
taining CAR and makes dynamic cytoskeletal arrangement.
They also demonstrated that podocin and CAR exhibit a dif-
fuse punctate pattern throughout the cytoplasm in both pro-
teins’ co-transfected COS-7 cells.
Regarding PAN, the intraperitoneal injection of PA to rats
is an experimental model characterized by massive protein-
uria and by marked morphological changes in podocytes,
including the effacement of foot processes, their focal adhe-
sion with Bowman’s capsules and the focal detachment from
the GBM (Asanuma et al. 2003; Diamond et al. 1986;
Nosaka et al. 1997). Thus, PA-induced nephrosis is regarded
as an experimental model of human nephrotic syndrome and
glomerulosclerosis.
In this paper, we demonstrate that podocin is translocated
to the cytoplasm by endocytosis in both the PAN rat model
and in poor-prognosis human immunoglobulin A nephropa-
thy (IgAN) specimens using the difference in the staining of
podocin and synaptopodin (synpo). This novel approach
shows that podocin is translocated to the cytoplasm in the
human nephropathy specimens and may help advance the
understanding of podocin endocytosis.
Materials and methods
Antibodies
The monoclonal mouse anti-synaptopodin antibody (Progen,
Heidelberg, Germany), Alexa 488 conjugated donkey anti-
rabbit IgG antiserum (Invitrogen, CA, USA), Alexa 555
conjugated goat anti-mouse IgG antiserum (Invitrogen),
mouse monoclonal Rab5 antibody (#50523 Abcam, Japan)
and the 5-nm colloidal-gold-conjugated goat anti-rabbit IgG
antiserum (heavy and light) (BB International, Cardiff, UK)
were purchased for immunohistochemistry and/or
immunoelectron microscopy. Polyclonal rabbit anti-podocin
antiserum has been described previously (Schwarz et al.
2001).
Experimental animals
Adult male Sprague–Dawley rats (weighing about 200 g)
were obtained from the Sankyo laboratory service (Tokyo,
Japan).
For PAN, a single dose (15 mg/100 g BW) of PA
(Sigma, St. Louis, USA) was injected intraperitoneally into
the rats to induce a nephrotic state, as described previously
(Inokuchi et al. 1996; Kihara et al. 1995). These rats were
housed under specific pathogen-free (SPF) conditions using
individual metabolic cages with free access to standard
chow and drinking water. Twenty-four-hour urine was col-
lected once a week throughout the experiments. Urinary
albumin, urinary total protein and creatinine were measured
by the same methods as clinical examination. All experi-
ments were performed according to the guidelines of the
Committee on Animal Experiments of Juntendo University,
Tokyo, Japan.
Three rats per group were sacrificed at 0, 4, 7, 14 and
28 days after PA injection. After the rats were anesthetized
with Pentobarbital sodium (100 mg/kg; Dainippon
Sumitomo Pharma, Osaka, Japan), they were perfused via
the abdominal aorta with a PLP fixative buffer (4 % parafor-
maldehyde in 0.1 M lysine). After perfusional fixation, the
kidneys were removed and processed for immunofluores-
cence and immunoelectron microscopy. Tissue slices were
filled in Tissue-Tek O.C.T. compound (Sakura Finetek,
USA), frozen in liquid nitrogen and then stored at −80 °C prior
to immunofluorescence.
Human tissue samples
For specimens of human IgA nephritis, tissue samples were
obtained from the samples of diagnostic renal biopsies per-
formed at JuntendoUniversity Hospital with the permission of
the Ethics Committee on Human Research of Juntendo
University Faculty of Medicine. We investigated the samples
from four groups of four patients, IgAN-good, IgAN-
relatively-good (IgAN-r-good), IgAN-relatively-poor (IgAN-
r-poor) and IgAN-poor, who had IgA nephropathy diagnosed
according to the second guideline of IgA nephropathy
(Tomino et al. 2003). As control human samples, we used
biopsy samples from patients with minor glomerular abnor-
malities (n=4).
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Immunofluorescence
For the immunofluorescent staining of rat kidneys, 4-μm-
thick sections on sillan-coated slide glass were washed in
PBS and incubated with a blocking solution. A double immu-
nofluorescent staining for podocin and synpo was then per-
formed and the secondary antibodies were incubated.
Human kidney biopsy specimens were stored at −80 °C for
immunofluorescence. The 4-μm-thick sections were fixed
with cold acetone for 5 min, washed with PBS, incubated with
a blocking solution and then a double immunofluorescent
staining for podocin and synpo was performed using the same
methodology as with the PAN rats. These sections were
photographed under a confocal laser microscope (Olympus
FV1000, Tokyo, Japan).
To examine the podocin gap, or the staining gap between
the area of podocin and synpo, at least 50 mid-sections of
podocin and synpo areas were carefully measured using a
digitizer KS-400 Imaging System as described previously
(Tanimoto et al. 2004) and the podocin gap was calculated
using the following formula:
podocingap %ð Þ ¼ podocin fluorescent stainingarea−synpo fluorescent stainingareað Þ=areaof eachglomerulus 100:
Immunoelectron microscopy
Animals were perfused with physiological saline and subse-
quently with a PLP fixative. The perfused kidneys were cut into
small pieces and immersed in the same fixative for 30 min. The
samples were dehydrated with a graded series of ethanol and
embedded in an LR-white resin (London Resin, Berkshire, UK)
(Ichimura et al. 2009). Ultrathin gold sections of the LR-white-
resin-embedded samples were produced with a diamond knife
and transferred to nickel grids (150 mesh) that had been coated
with a Formvar membrane. After blocking with a 1 % normal
goat serum in PBS (pH 7.4), the sections were incubated over-
night with the anti-podocin antiserum (1:50) diluted with 1 %
BSA in PBS at 4 °C for 12 h. Subsequently, they were incubat-
ed with colloidal-gold-conjugated secondary antibodies (BB
International) diluted 1:100 with 1 % BSA in PBS for 1 h at
room temperature, contrasted with 4 % uranyl acetate for 5 min
and observed with an H7100 transmission electron microsope
(Hitachi High-Technologies, Tokyo, Japan). The primary anti-
bodies were omitted from the incubation solution as a negative
control and no non-specific staining of the secondary antibody
was found in the kidney sections.
To confirm the alteration of localization of podocin in PAN
rats, pictures from at least 15 podocyte cell bodies from each
day were taken after an immunoelectron microscopic study.
The immunogold podocin particles in the podocyte cell body
were counted.
To examine the localization of podocin in human IgAN,
tissues were taken with needle biopsy. Small cortical pieces
were incubated in a PLP fixative buffer for a few hours and
embedded in LR-white, the same as with the rat kidney tissues.
Statistical analysis
All values are means±SEM. Statistical significance (defined
as p<0.05) was evaluated using Stat View followed by the
Fisher’s paired least significant difference t test.
Results
PAN rats showed significant proteinuria
A single intraperitoneal injection of PAN produced overt
proteinuria on days 4–28 (Fig. 1). We compared the
levels of proteinuria at each time point from day 0.
All time points, or days 4, 7, 14 and 28, showed sig-
nificant proteinuria (p<0.001). On day 28, the levels of
proteinuria had decreased from the peak levels observed
on day 14.
Fig. 1 Puromycin aminonucleoside nephrosis rats showed significant
proteinuria. Urinary protein was measured before and after the
peritoneal injection of PA (15 mg/kg) to rats (n ≥ 4). On days 4, 7, 14
and 28 urinary protein was significantly increased (p<0.001) (mean±SE)
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PAN rats showed a difference in the staining of podocin
and synpo on days 7 and 14
Although on days 4 and 7 the expression of podocin and
synpo were decreased, they were recovered on days 14 and
28 (Fig. 2a–e). The expression of podocin seemed to follow a
linear pattern (similar to the glomerular basement membrane;
GBM type) on days 4 and 7 and a podocyte cell body pattern
on days 14 and 28. On the other hand, the linear staining of
synpo did not change during the period from day 4 to day 28.
On day 0, the staining patterns of podocin and synpo were
almost matched (Fig. 2a). On days 7–14, the area of podocin
seemed to be translocated to the cell body area from the foot
process area; however, synpo stayed in the foot process area
(Fig. 2c, d).
On day 28, their merged area was relocated to the foot
process area (Fig. 2e). To confirm the difference of the
podocin-synpo area, we calculated the podocin gap (see
BMaterials and methods^) with the use of computer software
by subtracting the synpo area from the podocin area and di-
viding the total by the glomerulus area (Fig. 2f). On days 7–
14, the podocin gap was significantly increased (p<0.05) and
on day 28, the area returned to the same size as measured on
day 0.
Podocin was translocated to the cytoplasm of PAN rats at day
14
In the immunoelectron microscopy of PAN rats, immunoreac-
tive podocin was recognized by gold particles (Fig. 3a, b, c:
low magnification ×8000–×20,000, 3a’, b’, c’: high magnifi-
cation ×10,000–×50,000). On day 0, podocin was recognized
at the slit diaphragm insertion sites of foot processes (Fig. 3a,
day 0). On day 7, the structure of the slit diaphragm was
destroyed and the podocin was translocated to the cell bodies
of the podocytes (Fig. 3b, day 7). On day 14, through staining,
podocin was seen in the vesicular structures in the cell bodies
of podocytes (Fig. 3c, day 14). These data indicate that the
podocin was translocated to the cell body, likely by
endocytosis.
Fig. 2 a–e Double fluorescence of podocin (green), synaptopodin
(synpo) (red) and merged (yellow) in PAN rats. On day 4, the
expression of podocin was decreased and the snypo area seemed larger
than that of podocin but on days 7 and 14, the pattern of podocin staining
had changed from a linear to cytoplasmic pattern. On day 28, the areas of
both stainings were similar to control conditions (day 0). Scale bars (a–e)
50 μm. f Changes in the discrepancy staining area with podocin and
synpo for each time course. We measured the podocin gap, the
difference in the fluorescence staining area between podocin and synpo
for each time point specimen for over 50 glomeruli using specific
computer software (the mathematical formula is above this legend).
KS400 software; see “Materials and methods”). On days 7 and 14, the
gap was significantly increased (n ≥ 50) (p<0.05) (mean±SE)
Fig. 3 a–c Immunoelectron microscopy of podocin in PAN rats.
Podocin moved from the slit diaphragm area to the cytoplasmic area
as a form of vesicles at day 14 in the podocytes. Scale bars (a–c, a’–
c’)50 nm. Left low-magnification images (×8000–×20,000) and right
high-magnification images (×10,000–×50,000). d Podocin
significantly moved to the cytoplasm of podocytes on days 7 and 14
in PAN rats. The number of gold particles (podocin) was calculated in
the cytoplasmic area of podocytes. On days 7 and 14, podocin was
significantly increased in the cytoplasmic area in podocytes (n ≥ 15)
(p<0.05) (mean±SE)
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By counting the number of gold particles in the cytoplasm
of the podocytes, we could detect significantly more podocin
in the cytoplasm on days 7 and 14, as compared to day 0
(Fig. 3d, p<0.05).
The podocin gap was significantly increased in IgAN-poor
prognosis specimens
Each of the four IgAN groups consisted in four samples that
were stained with podocin and synpo (Fig. 4a–e). In the
IgAN-good group, the podocin and synpo stained areas were
consistently similar to day 0 in PAN rats (Fig. 4b, IgAN-
good). In the IgAN-r-good group, the level of expression
was decreased but both of them were merged completely
(Fig. 4c, IgAN-r-good). In the IgAN-r-poor group, there was
no evident change from the IgAN-good group (Fig. 4d, IgAN-
r-poor). Surprisingly, in the IgAN-poor group, podocin was
stained in the cell bodies of podocytes and there was a clear
difference in the staining pattern between podocin and synpo.
This result suggests the translocation of podocin to the cyto-
plasm. We also measured the podocin gap in each human
biopsy sample from IgAN (Fig. 4f) using the previously men-
tioned software. The podocin gap was not altered in the IgAN-
r-good and IgAN-r-poor groups when compared to the control
group. However, in the IgAN-poor group it was significantly
increased (p<0.05) when compared to the area of the IgAN-r-
Fig. 4 a–e Double fluorescence of podocin (green), synpo (red) and
merged (yellow) in IgA Nephropathy. In IgAN-good, −r-good and -r-
poor specimens, the staining areas of podocin and synpo were almost
the same but the IgAN-poor podocin area (not merged with synpo,
green) was larger than that of the other groups and the staining pattern
had changed from a linear type to cell body type. Scale bars (a–e) 50 μm.
f The changes in the discrepancy staining area with podocin and synpo in
each prognosis categories of IgAN. We measured the podocin gap (see
Fig. 2f). In IgAN-r-good specimens, the gap was decreased as compared
with that of the control but interestingly, in the IgAN-poor group, the gap
was significantly increased (p<0.05) compared with that of IgAN-r-good
control specimens, i.e., minor glomerular abnormality (n ≥ 4) (mean±SE)
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good group, indicating that podocin translocated to the cell
bodies of podocytes.
Podocin was translocated to the cytoplasm in IgAN poor
prognosis specimens
We next performed immunoelectron microscopy using an
anti-podocin antibody in kidney biopsy specimens of minor
glomerular injury and IgAN-poor specimens (Fig. 5a–c).
Podocin was located in the SD area of the control specimen.
On the other hand, in the IgAN-poor biopsy specimens, the
structure of the foot processes was destroyed and podocin was
translocated to the cytoplasm area (Fig. 5b, c, IgAN-poor).
Podocin was translocated to the cytoplasm by the endocytosis
pathway
As mentioned above, at day 14 of PAN rats, podocin was
translocated to the cell body area from foot processes. To
check this translocation mechanism, we stained PAN rats
specimens at day 14 with podocin and Rab5 (early endosome
marker) (Fig. 6a, b). Several podocytes were merged with
Rab5 and this result indicated that podocin was translocated
to cytoplasm by the endocytosis pathway.
Podocin was not translocated to the cytoplasm in minimal
change disease
We evaluated the podocin gap in human minimal change dis-
ease (MCD) biopsy specimens. Podocin and synpo merged
clearly and no podocin gap could be detected inMCD (Fig. 7).
Discussion
In this paper, we demonstrated that podocin was translocated
from the SD area to the cytoplasm area by the endocytosis
pathway in PAN rats and in the IgAN-poor prognosis group.
We defined the podocin gap as follows: the difference in the
staining pattern between podocin and synpo, which are foot
processes proteins. Podocin is especially prevalent in the SD
but synpo is located beside actin bundles in the foot processes
(Shirato et al. 1996). As we demonstrated before, synpo is a
critical protein for podocytes and for organizing their structure
(Asanuma et al. 2006). In the absence of synpo, the podocytes
lose essential stress fibers and their cell bodies shrink so as to
resemble a fibroblast. On the other hand, SD proteins were
naturally translocated from SD to the cytoplasm and kept their
structure (Soda and Ishibe 2013). Within a diseased condition,
the endocytosis system of SD proteins may become damaged
and the damage may accelerate podocyte injury. Thus, we
hypothesize that the difference of localization between
podocin and synpo may occur during podocyte injury.
During proteinuria conditions, the difference between the lo-
calization of podocin and synpo was significantly more evi-
dent than during normal conditions. To focus on the podocin
gap, we checked the localization of podocin and therefore we
also demonstrated that podocin was translocated to the cyto-
plasmic area with immune electron microscopy. Although
podocin was translocated to the cytoplasm, it does not corre-
late to the level of proteinuria. Actually, the podocin gap was
not found in either MCD, IgAN-r-good or IgAN-r-poor spec-
imens. We estimated that the translocation of podocin hap-
pened in severe podocyte injury.
Soda et al. (2012) reported that double knocked-out
dynamin-1 and -2 mice, synaptojanin knocked-out mice and
Fig. 5 a–c Immunoelectron microscopy of podocin in the control and
IgAN-poor group. Podocin was translocated from the slit diaphragm area
to the cytoplasmic area in the IgAN-poor group. Scale bars (a, a’, c’)
500 nm, (b, b’, c) 2 μm. Normal glomerulus: minor glomerular
abnormalities. Left low-magnification images (×8000), right high-
magnification images (×30,000)
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triple endophilin-1, -2, and -3 knocked-out mice showed sig-
nificant proteinuria and foot process effacement. They further
demonstrated that synaptojanin and endophilin, which are
functional partners of dynamin in synaptic vesicle endocytosis
at neural synapses, were critically implicated in the develop-
ment of the permeability barrier of kidneys. This paper indi-
cated that the system of endocytosis in the podocytes is a
critical phenomenon and that it is tightly connected to protein-
uria and foot process effacement (FPE), further worsening the
podocyte injury (these knocked-out mice displayed a lethal
kidney failure).
Recent evidence suggests that endocytosis may play a
vital role in the internalization and recycling of nephrin
(Tossidou et al. 2010). Phosphorylation (Quack et al.
2006) and the stimulation of high glucose (Tossidou et al.
2010) may initiate nephrin endocytosis and depend on CIN/
RukL, the homologue of CD2AP (Tossidou et al. 2012).
Focusing on endocytosis, Qin et al. (2009) demonstrated that
a raft-mediated endocytic pathway internalizes nephrin and
Godel et al. (2013) demonstrated that the trafficking of
podocin is dependent on the raft-mediated, non-conventional
endocytic pathway. This seems to be consistent with the sug-
gestion for endocytic trafficking of other prohibitin-domain
proteins (Langhorst et al. 2005). Intriguingly, the podocin-
related protein flotillin-1 defines a clathrin-independent
endocytic pathway (Glebov et al. 2006), which could lead to
the hypothesis that podocin not only assembles members of
the slit diaphragm but also orchestrates its internalization via a
self-defined pathway (Godel et al. 2013). In this study, we
demonstrated that podocin merged with Rab5 in PAN rats at
day 14. At the same time, the podocin gap was significantly
elevated, indicating that podocin was translocated to the cyto-
plasm by the endocytosis pathway. Because Rab5 is a typical
CME marker, it shows evidence that podocin interacts with
the CME pathway.
The Wiggins group demonstrated that a single dose of PA
caused podocytes depletion that results in minor glomerular
sclerosis (Kim et al. 2002). As a podocyte injury model, we
used PAN rats with a single peritoneal PA injection with the
same methods of the Wiggins’ group. For our model of
podocyte injury, we used PAN rats prepared with a single
peritoneal PA injection, just as the Wiggins’ group used for
their experiment. PA induces oxidant injury in cells via the
xanthine oxidase pathway and it was used as a similar model
of MCD and focal segmental nephron sclerosis in human
(Seckin et al. 2012). We evaluated PAN rats samples, which
showed podocytes detachment and glomerular sclerosis.
Clinically, MCD does not show such podocyte change with-
out FPE, so we used this model as a podocytes injury mod-
el. We also tried to stain the podocin gap in human MCD;
however, there was no difference in the podocin and synpo
staining (Fig. 7).
Fig. 6 a, b Podocin and Rab5
merged in samples from day 14
PAN rats. We performed double
staining of podocin and Rab,
which is a specific early
endosome marker, in day 14 PAN
rats specimens and detected
several locations where podocin
clearly merged with Rab5
(arrow). This suggests podocin
translocation to the cytoplasm by
endocytosis. Scale bars 50 μm
Fig. 7 In humanMCD, podocin and synpo clearly merged and there was
no significant podocin gap. Evaluation of the podocin gap in human
MCD specimens showed that podocin and synpo stained the same foot
process area. We did not find any evidence of podocin translocation.
Scale bar (a) 50mm
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Recently, two papers demonstrated that FPE has been
interpreted as a protective response of podocytes in danger
of detachment (Kriz et al. 2013; Kriz and Lemley 2014).
This FPE is typically observed in MCD and in other glomer-
ulonephritis. Similarly, PAN rats and IgAN patients also show
these pathological findings. The point is that the podocin gap
was observed only on PAN days 7, 14 and IgAN-poor. These
pathological findings show severe glomerular damage and
podocytes injury. Compared to FPE, the podocin gap was only
seen in severe conditions and we thought it could be a predic-
tive factor to assess the IgAN.
IgAN is the most common primary glomerulonephritis.
An often insidious progression to end-stage kidney disease
in 25–40 % of cases is accompanied by the development of
glomerulosclerosis (Rychlik et al. 1999). It is characterized
by the mesangial deposition of IgA, associated with
mesangial cell proliferation and mesangial matrix expansion.
In addition to these common histologic abnormalities, other
glomerular abnormalities, such as segmental sclerosis, cres-
cent formation and adhesion to the bowman capsules, are
detected. Other indicators, such as the number of podocytes
per glomerulus, might serve as a parameter of podocyte
injury and provide prognostic information for patients with
IgAN (Hishiki et al. 2001). Lemley et al. (2002) reported
that podocytopenia is associated with increasing disease se-
verity in IgAN. The clinical course of IgAN is variable. The
prevalence of clinically silent IgAN may be surprising high;
in a Japanese study, 16 % of donor kidneys had glomerular
IgA deposits and nearly 2 % exhibited mesangioproliferative
changes with C3 deposits characteristic of IgAN (Suzuki
et al. 2003). Mesangial IgA is exclusively of the IgA1 sub-
class and is deficient in galactose (Suzuki et al. 2011). Besides
these findings, the proceeding mechanisms of IgAN are still
obscure. Therefore, we focused on the difference in patholog-
ical characterizations of IgAN. On this basis, we divided
IgAN samples into 4 categories, following the indicators of
the Japan Committee of IgAN 2002 and assessed each spec-
imen. Only the poor prognosis specimens showed a signifi-
cant difference in the podocin gap and this showed a translo-
cation of podocin to cytoplasm by endocytosis. Based on the-
se results, we hypothesize that podocin traffic may lead to
severe podocyte injury or may happen in severely injured
podocytes.With these results, we postulate that podocin traffic
may also predict the prognosis of an IgAN disease course.
When evaluating IgAN, the patient’s samples are very im-
portant for estimating their prognosis; however, at present, we
do not have a specific staining reference. If endocytosis is
more fully understood, the movement of some proteins may
be the key to knowing the turning point between reversible
change and irreversible change.
In the future, the role of podocin traffic may help shed light
on the mechanism of podocyte injury and indicate a medical
approach to prevent the advancement of the disease course.
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